We are live on ! Find out more
ST

SAL Trading Portfolio holdings

AUM $57M
1-Year Est. Return 33.89%
This Fund
S&P 500
This Quarter Est. Return
-8.75%
1 Year Est. Return
+33.89%
3 Year Est. Return
+18.85%
5 Year Est. Return
10 Year Est. Return
AUM
$430M
AUM Growth
+$184M
Cap. Flow
+$202M
Cap. Flow %
46.89%
Top 10 Hldgs %
74.44%
Holding
61
New
30
Increased
9
Reduced
11
Closed
11

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$13.5M
2
RYAAY icon
Ryanair
RYAAY
+$6.31M
3
NVO
Novo Nordisk
NVO
+$4.45M
4
STLA icon
Stellantis
STLA
+$653K

Top Sells

Rank Stock Value
1
NOK icon
Nokia
NOK
+$26.9M
2
BP icon
BP
BP
+$10.8M
3
AZN icon
AstraZeneca
AZN
+$9.15M
4
STM icon
STMicroelectronics
STM
+$2.39M

Sector Composition

Rank Sector Weight
1 Technology 24.8%
2 Healthcare 5.12%
3 Energy 2.18%
4 Industrials 1.24%
5 Consumer Discretionary 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOK icon
1
Nokia
NOK
$47.7B
$107M 24.8%
19,532,257
-4,864,600
-20% -$26.9M
ASML icon
2
PUT
ASML
ASML
$612B
$49.6M 11.53%
74,200
+46,200
+165% +$30.9M
BHP icon
3
CALL
BHP
BHP
$213B
$31.9M 7.41%
+462,637
New +$28.1M
LIN icon
4
PUT
Linde
LIN
$236B
$29.7M 6.9%
+92,900
New +$28.7M
SHEL icon
5
CALL
Shell
SHEL
$244B
$21.3M 4.95%
+387,100
New +$20.6M
NVS icon
6
PUT
Novartis
NVS
$301B
$20.5M 4.77%
+233,600
New +$20.2M
SHEL icon
7
PUT
Shell
SHEL
$244B
$17.7M 4.12%
+322,700
New +$17.1M
ASML icon
8
CALL
ASML
ASML
$612B
$16.9M 3.93%
25,300
+22,400
+772% +$15M
NVS icon
9
Novartis
NVS
$301B
$13.7M 3.18%
+155,783
New +$13.5M
SAP icon
10
CALL
SAP
SAP
$216B
$12.3M 2.85%
+110,400
New +$13.4M
ABB
11
PUT
DELISTED
ABB Ltd
ABB
$11.7M 2.73%
+362,500
New +$12.6M
RIO icon
12
CALL
Rio Tinto
RIO
$153B
$10.6M 2.46%
131,800
+116,000
+734% +$8.81M
BP icon
13
BP
BP
$112B
$9.39M 2.18%
319,422
-355,757
-53% -$10.8M
RYAAY icon
14
PUT
Ryanair
RYAAY
$30.1B
$8.51M 1.98%
244,250
+221,750
+986% +$9.12M
NVO
15
Novo Nordisk
NVO
$229B
$5.99M 1.39%
107,800
+86,800
+413% +$4.45M
PHG icon
16
CALL
Philips
PHG
$25.5B
$5.89M 1.37%
+233,771
New +$6.39M
SNY icon
17
PUT
Sanofi
SNY
$108B
$5.46M 1.27%
+106,400
New +$5.49M
RYAAY icon
18
Ryanair
RYAAY
$30.1B
$5.35M 1.24%
+153,445
New +$6.31M
RIO icon
19
PUT
Rio Tinto
RIO
$153B
$5.24M 1.22%
+65,200
New +$4.95M
BCS icon
20
PUT
Barclays
BCS
$88.5B
$4.52M 1.05%
+572,100
New +$5.84M
LIN icon
21
CALL
Linde
LIN
$236B
$4.47M 1.04%
14,000
+12,900
+1,173% +$3.99M
BTI icon
22
PUT
British American Tobacco
BTI
$135B
$3.33M 0.77%
+79,000
New +$3.37M
AZN icon
23
CALL
AstraZeneca
AZN
$268B
$2.69M 0.62%
+20,000
New +$2.4M
DEO icon
24
PUT
Diageo
DEO
$49.4B
$2.58M 0.6%
+12,700
New +$2.54M
AZN icon
25
AstraZeneca
AZN
$268B
$2.37M 0.55%
17,850
-76,288
-81% -$9.15M

Similar funds

SAL Trading's Q1 2022 Portfolio in Review

As of Q1 2022, SAL Trading held 61 positions worth $430M, up 75% from $246M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

SAL Trading deployed $202M of net new capital in Q1 2022, opening 30 new positions and adding to 9 existing holdings. Its largest new stake was Novartis: 155,783 shares worth $13.7M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 63% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Nokia, an estimated $26.9M trimmed.

  • SAL Trading's largest Q1 2022 buy was Novartis: 155,783 shares worth $13.7M.
  • SAL Trading added most to Novo Nordisk in Q1 2022, an estimated $4.45M increase.
  • SAL Trading's biggest Q1 2022 reduction was Nokia, cutting an estimated $26.9M.
  • SAL Trading fully exited STMicroelectronics in Q1 2022, selling an estimated $2.39M.
  • SAL Trading's ten largest holdings make up 74% of its $430M portfolio in Q1 2022.
  • SAL Trading opened 30 new positions and closed 11 in Q1 2022.
  • SAL Trading's portfolio value rose 75% quarter-over-quarter to $430M.

Based on SAL Trading's 13F filing for Q1 2022, filed 16 May 2022.